Are you commercializing a technology in the biotech or biopharma space? We want to meet you.

QB3 provides startups with expertise and mentorship from stakeholders across the life science spectrum. We're inviting startups to pitch our panel of judges (a mix of financial/strategic investors, subject matter expertise and clinicians). We'll select 10 as the final cohort of the QB3 Biotech/Biopharma Summit. If selected, you will:

 
  • Present to a select group of investors and industry partners.

  • Receive coaching in communications, product development, IP, regulatory, reimbursement, marketing and business strategy from our network of experts.

  • Showcase your startup at the public pitch session Thursday, November 7, 2019.

  • Be eligible to be chosen to receive a range of valuable in-kind services to help you accelerate your technology.

 

Who Can Apply

Early-stage life science companies (up to and including Series A investment) based in California, or with a senior leadership position based in California. No university affiliation is required. If you have submitted an application in previous years but not been chosen for the final cohort, we welcome you to apply again if your company has made progress.

 

Key Dates

September 20: Deadline to apply

September 27: First round of selection: qualified startups notified

October 9/10: Startups present to judging panel at the UCSF Mission Bay campus

October 11: Startups notified whether chosen for final cohort

November 7: Morning: Final cohort pitches investors & partners in private session at Genentech Hall, UCSF Mission Bay

 

How to Apply

Applications will be accepted through Friday, September 20, 2019. Scroll down to view the guidelines for your application slide deck (which should be more detailed than a deck you would use for a live presentation). Submit your application through our secure online system by clicking the button below. Note: the platform is SurveyMonkey Apply, which requires that you first register for an account (a quick process), and then apply for the QB3 Biotech/Biopharma Pitch Summit.

Sponsor

 
 

Win In-Kind Services

Our participating partners will choose the recipients of their services from among the 10 companies in the final cohort. Criteria include technology, market potential, and how much a startup would benefit from a particular service. More services to come as our partners are continually updated. Visit the In-Kind Services page for full details.

Application slide deck guidelines

Please keep in mind that this deck will be reviewed by itself, without other material; make sure to be as clear as possible. It should be more detailed than a deck that you would use for a live presentation. Also, please be sure to keep your deck non-confidential. Decks labeled confidential cannot be accepted.

The deck must adhere to the following structure with 12 slides in total:

  • Slide 1 Include your name, company, and contact information.

  • Slide 2 What is the specific problem you are trying to solve? Provide some background on the scale of this problem and the market opportunity.

  • Slide 3 Who are your customers/users? How are they currently trying to solve this problem, and what’s lacking in this solution?

  • Slide 4 What is your company going to do? Describe the technology behind your product or service. How is your product/technology transformational?

  • Slide 5 What evidence do you have that your technology will achieve this goal? Showing some data here can be helpful. What is the current stage of your technology?

  • Slide 6 What IP protection do you have or anticipate having?

  • Slide 7 What is your business model? Also address your regulatory approach, if relevant.

  • Slide 8 Explain the current status of your startup and the development stage of your product/technology: what does the near future looks like?

  • Slide 9 What happens beyond the next milestones? Describe the longer term plan and timeline for your startup from the technical and business strategy perspectives.

  • Slide 10 How much funding have you raised (from grant sources as well as private capital)? How much money do you hope to raise at this time? How do you plan to use the funds you raise to achieve key milestones?

  • Slide 11 Who are your competitors and how do your value propositions compare with theirs? Provide a complete view.

  • Slide 12 Who are the key team members on your management team, board of directors and board of advisers, as well as any major investors. Why is your team best-positioned to advance the product/technology you are developing? Elaborate on key skills/expertise, history of how and why the team was formed.